DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

LinksSchließen

Referenz

Etscheid M, Breitner-Ruddock S, Gross S, Hunfeld A, Seitz R, Dodt J.
Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products.

Vox Sang 2012;
102 (1) 40-46

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: